Mirae Asset Global Investments’s Adaptive Biotechnologies ADPT Stock Holding History
Bought
Maintained
Sold
Other funds holding ADPT
VCM
VPM
Mirae Asset Global Investments's ADPT Position: Q1 2026 in Review
Mirae Asset Global Investments increased its Adaptive Biotechnologies (ADPT) stake by 8.3% in Q1 2026, buying an estimated $9.77K and bringing the position to 8,032 shares worth $111K. The position accounts for ﹤0.01% of the portfolio, ranked #1163.
Mirae Asset Global Investments first reported a position in ADPT in Q3 2019 and has held it in 17 quarters since. The position peaked at $5.18M in Q3 2019. 295 funds tracked by Wall St. Rank hold ADPT as of Q1 2026.
- Mirae Asset Global Investments held 8,032 shares of Adaptive Biotechnologies worth $111K as of Q1 2026.
- Mirae Asset Global Investments bought 613 Adaptive Biotechnologies shares in Q1 2026, an estimated $9.77K.
- Adaptive Biotechnologies made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q1 2026, its #1163 holding.
- Mirae Asset Global Investments first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 17 quarters since.
- Mirae Asset Global Investments's Adaptive Biotechnologies position peaked at $5.18M in Q3 2019.
- 295 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q1 2026.
Based on Mirae Asset Global Investments's 13F filing for Q1 2026, filed 4 May 2026.